BIIB : Biogen stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2025-04-22 |
|---|---|---|---|---|
| 2025 | $129.74 | $117.61 | $165.38 | 9.13% |
| 2026 | $342.02 | $192.01 | $441.59 | 187.68% |
| 2027 | $469.08 | $446.64 | $495.68 | 294.55% |
| 2028 | $550.78 | $501.94 | $615.8 | 363.27% |
| 2029 | $724.27 | $637.23 | $788.23 | 509.2% |
| 2030 | $880.56 | $797.33 | $947.95 | 640.65% |
| 2031 | $886.44 | $873.22 | $941.3 | 645.6% |
| 2032 | $880.72 | $876.88 | $887.68 | 640.79% |
| 2033 | $848.57 | $809.42 | $886.59 | 613.75% |
| 2034 | $702.35 | $644.96 | $789.57 | 490.76% |
| 2035 | $644.54 | $642.0 | $645.83 | 442.13% |
The 31 Wall Street analysts offering Biogen stock forecast in the last 6 months have average price target of
$206.9 with a high forecast of $300.0 and a low forecast of $135.0.
The average Biogen stock forecast represents a 74.03%
increase from the last price of $118.889999389648.
For Biogen stock forecast for 2025, 8 predictions are offered for each month of 2025 with average Biogen stock
forecast of $129.74, a high forecast of $165.38, and a low forecast of $117.61.
The average Biogen stock forecast 2025 represents a 9.13%
increase from the last price of $118.889999389648.
For Biogen stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Biogen stock
forecast of $342.02, a high forecast of $441.59, and a low forecast of $192.01.
The average Biogen stock forecast 2026 represents a 187.68%
increase from the last price of $118.889999389648.
For Biogen stock forecast for 2028, 12 predictions are offered for each month of 2028 with average Biogen stock
forecast of $550.78, a high forecast of $615.8, and a low forecast of $501.94.
The average Biogen stock forecast 2028 represents a 363.27%
increase from the last price of $118.889999389648.
For Biogen stock forecast for 2030 (5 year), 12 predictions are offered for each month of 2030 with average Biogen stock
forecast of $880.56, a high forecast of $947.95, and a low forecast of $797.33.
The average Biogen stock forecast 2030 represents a 640.65%
increase from the last price of $118.889999389648.
For Biogen stock forecast 2031, 12 predictions are offered for each month of 2031 with average Biogen stock
forecast of $886.44, a high forecast of $941.3, and a low forecast of $873.22.
The average Biogen stock forecast 2031 represents a 645.6%
increase from the last price of $118.889999389648.
For Biogen stock forecast for 2035 (10 year), 4 predictions are offered for each month of 2035 with average Biogen stock
forecast of $644.54, a high forecast of $645.83, and a low forecast of $642.0.
The average Biogen stock forecast 2035 represents a 442.13%
increase from the last price of $118.889999389648.
Please, see more forecasts below.
BIIB : Biogen stock forecast by Wall Street Analysts
The average Biogen stock forecast from last 6 month is $206.9, and this show a -12.87% decrease in average from the prior price target of the each prediction. Also, this average forecast of $206.9 represents a -25.1% decrease from the past average forecast of $276.22, 6 months ago from 36 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2025-04-16 | Needham | Hold | ||
| 2025-04-09 | Morgan Stanley | $157.00 | $152 | Equal-Weight |
| 2025-04-04 | Argus Research | Hold | ||
| 2025-02-18 | Piper Sandler | $138.00 | $135 | Neutral |
| 2025-02-13 | Wells Fargo | $165.00 | $140.0000 | Equal-Weight |
| 2025-02-13 | Scotiabank | $244.0000 | $224.0000 | Sector Outperform |
| 2025-02-13 | BMO Capital | $156.0000 | $139 | Market Perform |
| 2025-02-13 | Morgan Stanley | $192.0000 | $157 | Equal-Weight |
| 2025-02-13 | Goldman Sachs | $281.0000 | $245 | Buy |
| 2025-02-13 | RBC Capital | $231.0000 | $225.0000 | Outperform |
| 2025-02-13 | Citigroup | $160.00 | $145.0000 | Neutral |
| 2025-02-13 | HC Wainwright & Co. | $300.0000 | $241.0000 | Buy |
| 2025-02-13 | Truist Securities | $220.00 | $210 | Buy |
| 2025-02-13 | Canaccord Genuity | $298.0000 | $265.0000 | Buy |
| 2025-02-13 | Needham | Hold | ||
| 2025-01-28 | Citigroup | $190.00 | $160.0000 | Neutral |
| 2025-01-10 | Wells Fargo | $190.0000 | $165.0000 | Equal-Weight |
| 2025-01-08 | Truist Securities | $302.00 | $220 | Buy |
| 2025-01-02 | Piper Sandler | $315.0000 | $138 | Neutral |
| 2024-12-20 | BMO Capital | $230.00 | $164 | Market Perform |
| 2024-12-10 | B of A Securities | $178.0000 | Neutral | |
| 2024-12-09 | Jefferies | $250.0000 | $180.0000 | Hold |
| 2024-11-21 | Mizuho | $251.00 | $207 | Outperform |
| 2024-11-18 | Needham | $270.00 | $270.00 | Hold |
| 2024-11-15 | Wolfe Research | Peer Perform | ||
| 2024-11-15 | Baird | $294.00 | $300 | Outperform |
| 2024-11-14 | Citigroup | $190.0000 | Neutral | |
| 2024-11-04 | JP Morgan | $220.0000 | $210.0000 | Neutral |
| 2024-10-31 | Morgan Stanley | $285.0000 | $204 | Equal-Weight |
| 2024-10-31 | Needham | $270.00 | $270.00 | Buy |
| 2024-10-31 | HC Wainwright & Co. | $300.00 | $300.00 | Buy |
| 2024-10-31 | TD Cowen | $300.0000 | $275.0000 | Buy |
| 2024-10-31 | Barclays | $190.00 | $180.0000 | Equal-Weight |
| 2024-10-31 | Oppenheimer | $270.00 | $255 | Outperform |
| 2024-10-30 | Needham | $270.0000 | $270 | Buy |
| 2024-10-17 | BMO Capital | $260.0000 | $230 | Outperform |
| 2024-10-10 | Raymond James | Market Perform | ||
| 2024-10-04 | RBC Capital | $292.00 | $269.0000 | Outperform |
| 2024-10-03 | UBS | $234.0000 | $202.0000 | Neutral |
| 2024-09-24 | Needham | $285.00 | $285.00 | Buy |
| 2024-09-23 | Wedbush | $210.00 | $205.0000 | Neutral |
| 2024-09-19 | RBC Capital | $292.00 | $292.00 | Outperform |
| 2024-09-09 | Cantor Fitzgerald | $292.0000 | $292 | Overweight |
| 2024-09-04 | Needham | $285.00 | $285.00 | Buy |
| 2024-08-19 | Needham | $285.00 | $285.00 | Buy |
| 2024-08-06 | Mizuho | $277.00 | $251 | Outperform |
| 2024-08-05 | Needham | $288.00 | $285.00 | Buy |
| 2024-08-05 | Truist Securities | $340.00 | $302.0000 | Buy |
| 2024-08-02 | Wedbush | $215.00 | $210 | Neutral |
| 2024-08-02 | Barclays | $200.00 | $190.0000 | Equal-Weight |
| 2024-08-02 | Scotiabank | $275.0000 | $244.0000 | Sector Outperform |
| 2024-08-02 | Wells Fargo | $240.00 | $225.0000 | Equal-Weight |
| 2024-08-02 | RBC Capital | $282.0000 | $292 | Outperform |
| 2024-08-01 | Needham | $288.0000 | $288 | Buy |
| 2024-07-29 | Baird | $316.00 | $294 | Outperform |
| 2024-07-26 | Needham | $294.00 | $294.00 | Buy |
| 2024-07-12 | Piper Sandler | $335.0000 | $313 | Overweight |
| 2024-06-28 | Needham | $294.00 | $294.00 | Buy |
| 2024-06-27 | RBC Capital | $317.00 | $317.00 | Outperform |
| 2024-06-26 | RBC Capital | $317.00 | $317.00 | Outperform |
| 2024-06-05 | RBC Capital | $317.00 | $317.00 | Outperform |
| 2024-05-29 | RBC Capital | $317 | Outperform | |
| 2024-05-23 | HC Wainwright & Co. | $300.0000 | Buy | |
| 2024-05-22 | Needham | $294.0000 | Buy | |
| 2024-05-16 | Truist Securities | $340.00 | $340 | Buy |
| 2024-05-03 | HSBC | $339.0000 | $342.0000 | Buy |
| 2024-04-29 | Oppenheimer | $270.00 | $270 | Outperform |
| 2024-04-25 | Needham | $294.00 | Buy | |
| 2024-04-25 | HC Wainwright & Co. | $325.00 | $300.0000 | Buy |
| 2024-04-25 | Wedbush | $213.0000 | $215 | Neutral |
| 2024-04-25 | Barclays | $215.00 | $200.0000 | Equal-Weight |
| 2024-04-24 | Needham | $294.00 | Buy |
Biogen stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2025-04-23 | $118.00 | -0.75% |
| 2025-04-24 | $119.10 | 0.94% |
| 2025-04-25 | $117.79 | -1.10% |
| 2025-04-28 | $118.57 | 0.66% |
| 2025-04-29 | $118.41 | -0.14% |
BIIB : Long term Biogen stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2025 May. is $119.76 , for 2026 Apr. is $288.05 , for 2029 Apr. is $700.31 , for 2030 Apr. is $845.55 , for 2034 Apr. is $739.89 , and for 2035 Apr. is $642.00.
BIIB : Biogen stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 May. | $119.76 | 0.73% |
| 2025 Jun. | $118.72 | -0.87% |
| 2025 Jul. | $117.61 | -0.94% |
| 2025 Aug. | $118.15 | 0.46% |
| 2025 Sep. | $122.21 | 3.43% |
| 2025 Oct. | $130.94 | 7.15% |
| 2025 Nov. | $145.16 | 10.86% |
| 2025 Dec. | $165.38 | 13.93% |
BIIB : Biogen stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $192.01 | 16.10% |
| 2026 Feb. | $224.28 | 16.81% |
| 2026 Mar. | $258.38 | 15.21% |
| 2026 Apr. | $288.05 | 11.48% |
| 2026 May. | $316.68 | 9.94% |
| 2026 Jun. | $345.63 | 9.14% |
| 2026 Jul. | $372.27 | 7.71% |
| 2026 Aug. | $394.40 | 5.95% |
| 2026 Sep. | $411.68 | 4.38% |
| 2026 Oct. | $424.77 | 3.18% |
| 2026 Nov. | $434.51 | 2.29% |
| 2026 Dec. | $441.59 | 1.63% |
BIIB : Biogen stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $446.64 | 1.14% |
| 2027 Feb. | $450.54 | 0.87% |
| 2027 Mar. | $454.12 | 0.79% |
| 2027 Apr. | $457.74 | 0.80% |
| 2027 May. | $461.46 | 0.81% |
| 2027 Jun. | $465.43 | 0.86% |
| 2027 Jul. | $469.69 | 0.92% |
| 2027 Aug. | $474.28 | 0.98% |
| 2027 Sep. | $479.17 | 1.03% |
| 2027 Oct. | $484.36 | 1.08% |
| 2027 Nov. | $489.86 | 1.13% |
| 2027 Dec. | $495.68 | 1.19% |
BIIB : Biogen stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $501.94 | 1.26% |
| 2028 Feb. | $508.75 | 1.36% |
| 2028 Mar. | $516.23 | 1.47% |
| 2028 Apr. | $524.36 | 1.57% |
| 2028 May. | $533.28 | 1.70% |
| 2028 Jun. | $542.51 | 1.73% |
| 2028 Jul. | $551.90 | 1.73% |
| 2028 Aug. | $561.39 | 1.72% |
| 2028 Sep. | $571.73 | 1.84% |
| 2028 Oct. | $583.56 | 2.07% |
| 2028 Nov. | $597.96 | 2.47% |
| 2028 Dec. | $615.80 | 2.98% |
BIIB : Biogen stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $637.23 | 3.48% |
| 2029 Feb. | $663.30 | 4.09% |
| 2029 Mar. | $687.81 | 3.70% |
| 2029 Apr. | $700.31 | 1.82% |
| 2029 May. | $711.94 | 1.66% |
| 2029 Jun. | $723.04 | 1.56% |
| 2029 Jul. | $733.86 | 1.50% |
| 2029 Aug. | $744.63 | 1.47% |
| 2029 Sep. | $755.67 | 1.48% |
| 2029 Oct. | $767.02 | 1.50% |
| 2029 Nov. | $778.26 | 1.46% |
| 2029 Dec. | $788.23 | 1.28% |
BIIB : Biogen stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $797.33 | 1.15% |
| 2030 Feb. | $808.26 | 1.37% |
| 2030 Mar. | $823.90 | 1.93% |
| 2030 Apr. | $845.55 | 2.63% |
| 2030 May. | $866.96 | 2.53% |
| 2030 Jun. | $882.31 | 1.77% |
| 2030 Jul. | $893.70 | 1.29% |
| 2030 Aug. | $905.25 | 1.29% |
| 2030 Sep. | $920.75 | 1.71% |
| 2030 Oct. | $934.14 | 1.45% |
| 2030 Nov. | $940.65 | 0.70% |
| 2030 Dec. | $947.95 | 0.78% |
BIIB : Biogen stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $941.30 | -0.70% |
| 2031 Feb. | $914.09 | -2.89% |
| 2031 Mar. | $894.13 | -2.18% |
| 2031 Apr. | $883.09 | -1.24% |
| 2031 May. | $877.98 | -0.58% |
| 2031 Jun. | $876.13 | -0.21% |
| 2031 Jul. | $875.45 | -0.08% |
| 2031 Aug. | $874.90 | -0.06% |
| 2031 Sep. | $874.09 | -0.09% |
| 2031 Oct. | $873.22 | -0.10% |
| 2031 Nov. | $874.46 | 0.14% |
| 2031 Dec. | $878.44 | 0.46% |
BIIB : Biogen stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $881.63 | 0.36% |
| 2032 Feb. | $882.06 | 0.05% |
| 2032 Mar. | $880.93 | -0.13% |
| 2032 Apr. | $879.33 | -0.18% |
| 2032 May. | $877.75 | -0.18% |
| 2032 Jun. | $876.88 | -0.10% |
| 2032 Jul. | $876.99 | 0.01% |
| 2032 Aug. | $877.85 | 0.10% |
| 2032 Sep. | $879.51 | 0.19% |
| 2032 Oct. | $882.31 | 0.32% |
| 2032 Nov. | $885.72 | 0.39% |
| 2032 Dec. | $887.68 | 0.22% |
BIIB : Biogen stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $886.59 | -0.12% |
| 2033 Feb. | $882.32 | -0.48% |
| 2033 Mar. | $875.63 | -0.76% |
| 2033 Apr. | $867.56 | -0.92% |
| 2033 May. | $859.17 | -0.97% |
| 2033 Jun. | $850.74 | -0.98% |
| 2033 Jul. | $842.40 | -0.98% |
| 2033 Aug. | $834.45 | -0.94% |
| 2033 Sep. | $827.38 | -0.85% |
| 2033 Oct. | $823.66 | -0.45% |
| 2033 Nov. | $823.56 | -0.01% |
| 2033 Dec. | $809.42 | -1.72% |
BIIB : Biogen stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $789.57 | -2.45% |
| 2034 Feb. | $773.08 | -2.09% |
| 2034 Mar. | $757.53 | -2.01% |
| 2034 Apr. | $739.89 | -2.33% |
| 2034 May. | $720.24 | -2.66% |
| 2034 Jun. | $699.39 | -2.90% |
| 2034 Jul. | $681.91 | -2.50% |
| 2034 Aug. | $668.10 | -2.02% |
| 2034 Sep. | $657.46 | -1.59% |
| 2034 Oct. | $650.04 | -1.13% |
| 2034 Nov. | $646.02 | -0.62% |
| 2034 Dec. | $644.96 | -0.16% |
BIIB : Biogen stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $645.41 | 0.07% |
| 2035 Feb. | $645.83 | 0.07% |
| 2035 Mar. | $644.90 | -0.14% |
| 2035 Apr. | $642.00 | -0.45% |
Financial Data for Biogen stock
Frequently Asked Questions about Biogen stock forecast
Is Biogen a good long term stock?
From Biogen stock forecast , Biogen (BIIB) stock can be a good investment choice. According to AIPickup, the Biogen stock price forecast for 2025 May. is $119.760609887111 From Biogen stock forecast , Biogen (BIIB) stock can be a good investment choice. According to AIPickup, the Biogen stock price forecast for 2026 Apr. is $288.050214251667 From Biogen stock forecast , Biogen (BIIB) stock can be a good investment choice. According to AIPickup, the Biogen stock price forecast for 2029 Apr. is $700.312478724917 From Biogen stock forecast , Biogen (BIIB) stock can be a good investment choice. According to AIPickup, the Biogen stock price forecast for 2030 Apr. is $845.55307965235 From Biogen stock forecast , Biogen (BIIB) stock can be a good investment choice. According to AIPickup, the Biogen stock price forecast for 2034 Apr. is $739.890260090872 From Biogen stock forecast , Biogen (BIIB) stock can be a good investment choice. According to AIPickup, the Biogen stock price forecast for 2035 Apr. is $642.002250939804
Is Biogen stock overvalued?
Biogen (BIIB) stock is expected to go UP . Therefore, AIPickup would say that Biogen (BIIB) stock is NOT overvalued.
Will Biogen stock price go up?
Yes. The Biogen stock price forecast for 2026 Apr. is $288.050214251667
Is Biogen stock a good buy now?
Since closing price on 2025-04-22 is $118.889999389648 and forecast for 2026 Apr. is $288.05, Biogen stock is a good 1 year investment.
14 Days Historical Data for Biogen stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| BIIB stock price for 2025-04-02 | $131.32 | $132.58 | $128.75 | $134.00 |
| BIIB stock price for 2025-04-03 | $130.71 | $132.37 | $130.05 | $133.77 |
| BIIB stock price for 2025-04-04 | $122.98 | $129.22 | $122.77 | $129.95 |
| BIIB stock price for 2025-04-07 | $119.19 | $121.81 | $117.40 | $123.77 |
| BIIB stock price for 2025-04-08 | $114.05 | $119.77 | $112.88 | $120.79 |
| BIIB stock price for 2025-04-09 | $120.49 | $110.31 | $110.04 | $121.08 |
| BIIB stock price for 2025-04-10 | $113.38 | $117.45 | $110.24 | $118.83 |
| BIIB stock price for 2025-04-11 | $115.17 | $114.32 | $112.18 | $116.39 |
| BIIB stock price for 2025-04-14 | $119.26 | $116.51 | $115.38 | $119.99 |
| BIIB stock price for 2025-04-15 | $116.98 | $118.81 | $116.61 | $119.93 |
| BIIB stock price for 2025-04-16 | $115.29 | $117.00 | $114.96 | $118.00 |
| BIIB stock price for 2025-04-17 | $118.61 | $115.02 | $114.66 | $118.77 |
| BIIB stock price for 2025-04-21 | $116.49 | $117.97 | $115.45 | $118.61 |
| BIIB stock price for 2025-04-22 | $118.89 | $118.12 | $117.40 | $119.71 |